This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Dow Global Technolgoies LLC, Newron Pharmaceuticals S.p.a., Rohm and Haas Company. Active years: 2025-2026.
Company Filing History:
1 out of 4,798 
1 out of 40 
1 out of 3,442 
Years Active: 2025-2026
Title: Weifang Zhang: Innovator in Pharmaceutical Chemistry
Introduction
Weifang Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work has led to the filing of a patent that showcases his innovative approach to drug development.
Latest Patents
Weifang Zhang holds a patent for a process for the production of substituted 2-[2-(phenyl)ethylamino] alkaneamide derivatives. This invention refers to a process for preparing a compound of formula (I) or a pharmaceutically acceptable salt thereof. The patent outlines various substituents and structural configurations that enhance the efficacy of the compounds developed.
Career Highlights
Zhang is currently employed at Newron Pharmaceuticals S.p.a., where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to improving therapeutic options through chemical innovation. He has successfully navigated the complexities of drug development, contributing to the advancement of new treatments.
Collaborations
Weifang Zhang has collaborated with esteemed colleagues, including William W. Leong and Dongxiao Lan. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Weifang Zhang's contributions to pharmaceutical chemistry exemplify the spirit of innovation in the field. His patent and ongoing work at Newron Pharmaceuticals S.p.a. highlight his dedication to advancing medical science.